Results 111 to 120 of about 320,592 (205)

Anti-HIV antibodies are representative of the latent reservoir but do not correlate with viral control in people with long-lasting virological suppression undergoing analytical treatment interruption (APACHE study). [PDF]

J Antimicrob Chemother, 2021
Mastrangelo A, Burbelo PD, Galli L, Poli A, Alteri C, Scutari R, Muccini C, Spagnuolo V, Caccia R, Turrini F, Bigoloni A, Galli A, Castagna A, Cinque P.   +13 more
europepmc   +1 more source

HIV Antibody [PDF]

, 2020
openaire   +1 more source

Blood Transfusions: Are They Life Saving or Transfusing Infections? [PDF]

, 2011
Introduction: There is a risk of 1 - 2 per 1000 recipients receiving contaminated blood with viral, bacterial and parasitic agents.TTI’S are the most commonly encountered complications in transfusion medicine.
Amrutha Kumari, B, Deepa, S, Venkatesha, D   +2 more
core   +1 more source

Plant-based production of highly potent anti-HIV antibodies with engineered posttranslational modifications. [PDF]

Sci Rep, 2020
Singh AA, Pooe O, Kwezi L, Lotter-Stark T, Stoychev SH, Alexandra K, Gerber I, Bhiman JN, Vorster J, Pauly M, Zeitlin L, Whaley K, Mach L, Steinkellner H, Morris L, Tsekoa TL, Chikwamba R.   +16 more
europepmc   +1 more source

HIV Antibody Measurement [PDF]

, 2020
openaire   +1 more source

MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-ASSOCIATED VACCINE PROTECTION FROM SIMIAN IMMUNODEFICIENCY VIRUS-INFECTED PERIPHERAL-BLOOD CELLS [PDF]

, 1994
Boes, J, Bontrop, RE, Cranage, M, de Vries, P, Dings, M, Dubbes, R, Heeney, JL, Jonker, M, Koornstra, W, Niphuis, H, Norley, S, Osterhaus, A, Otting, N, ten Haaft, P, van Els, C   +14 more
core   +1 more source

Defining criteria for broadly neutralizing HIV antibodies. [PDF]

Front Immunol
David-Fung ES, Belobrajdic KA, Macke JP, Quackenbush CR, Ganguly K, Mamrosh JL.   +5 more
europepmc   +1 more source

Heterologous combinations of VSV-GP and native-like trimers elicit autologous Tier 2 HIV antibodies in rabbits. [PDF]

NPJ Vaccines
Radvan F, Hauser A, Lin LY, Wilmschen-Tober S, Schaber M, Bermejo-Jambrina M, Agbabiaka TO, Peterhoff D, Riepler L, Mendrzyk N, Beierfuß A, Speth C, Moog C, von Laer D, Wagner R, Kimpel J.   +15 more
europepmc   +1 more source

Transient rapamycin treatment avoids unwanted host immune responses toward AAV-delivered anti-HIV antibodies. [PDF]

Nat Commun
Fuchs SP, Mondragon PG, Zabizhin R, Tomer S, Wang L, Cook E, Dudley DM, Weisgrau KL, Furlott J, Coonen J, Alexander E, Xie J, Gao G, Termini JM, Martinez-Navio JM, Zhen A, Desrosiers RC.   +16 more
europepmc   +1 more source

HIV antibodies in babies. [PDF]

BMJ, 1992
Connell JA, Parry JV, Mortimer PP, Burns SM, Klokke A, DE ROSSI, ANITA, GIAQUINTO, CARLO   +6 more
openaire   +2 more sources